The Plasmapheresis Market is projected to reach $2.55 billion by 2030, at a CAGR of 8.6% from 2023 to 2030. Plasmapheresis is the process of removal, treatment, and return/exchange of plasma from the body's circulatory system. It is performed for either therapeutic purposes or for collecting source plasma for the manufacturing of blood products.
For therapeutic purposes, this procedure is used to treat a variety of conditions, such as autoimmune diseases, blood disorders, and neurologic disorders. Plasmapheresis is carried out using an instrument that separates the plasma from the blood cells. The rising demand for source plasma and plasma exchange procedures for therapeutic purposes is driving demand for plasmapheresis systems globally.
The growth of this market is driven by the rising incidence of autoimmune diseases, increasing demand for source plasma from biopharmaceutical companies, and favorable reimbursement policies for plasmapheresis procedures. In addition, the rising demand for plasmapheresis from emerging countries is expected to provide significant growth opportunities for this market.
However, the high cost of plasmapheresis devices & procedures and the risks associated with plasmapheresis procedures are expected to hinder the growth of this market to a certain extent. In addition, factors such as the lack of awareness about plasmapheresis procedures and limited access and availability in certain regions are the major challenges to the growth of this market.
Increasing Demand for Source Plasma from Biopharmaceutical Companies to Drive Market Growth
There is an increasing demand for source plasma from biopharmaceutical companies owing to its use in treating an expanding list of debilitating, chronic and life-threatening disorders. Plasma can be separated from the whole blood with the help of plasmapheresis procedures. The source plasma is utilized by biopharmaceutical companies to produce plasma-derived therapies using plasma-fractionation techniques and several innovative processes.
Plasma-derived therapies are helpful in treating a wide range of chronic and life-threatening diseases. For instance, immunoglobulin (IG) is used to help patients suffering from primary and secondary immunodeficiency disorders and to combat viral and bacterial infections. There is a high demand for source plasma from biopharmaceutical companies with the help of plasmapheresis procedures.
In addition, the growing incidences of various rare diseases such as hereditary angioedema, hemophilia A & B, Von Willebrand disease, primary immunodeficiency disease (PID), chronic inflammatory demyelinating polyneuropathy (CIDP), and idiopathic thrombocytopenic purpura (ITP) are also driving the demand for plasma-derived products, thereby contributing to the growth of the plasmapheresis market.
Click here to: Get a Free Sample Copy of this report
Risk Associated with Plasmapheresis Procedures to Hinder Market Growth
During the plasmapheresis procedure, some amount of blood is removed from the human body, and certain replacement fluids such as albumin, fresh frozen plasma (FFP), electrolyte solutions, purified protein products, and starches are infused in the body to maintain intravascular osmotic pressure. The procedure is usually considered safe; however, there are still several risks associated with it. Some of the risk factors associated with the plasmapheresis procedure are the risk of infection, allergic reactions, low blood pressure, internal bleeding, and electrolyte imbalance, among others.
One of the most common side effects associated with the plasmapheresis procedure is the occurrence of hypotension or lowering of blood pressure which causes faintness, blurred vision, dizziness, sweating or abdominal cramps, but these can be controlled if treated immediately.
Some patients feel numbness or tingling around the mouth or nose, owing to the effect of citrate, an anticoagulant, on the calcium level in the body. Occasionally, bleeding can occur during the plasmapheresis procedure because of anticoagulants added to the blood, and if not treated immediately can result in irregular heartbeat and cardiac arrest. The replacement fluids sometimes cause an allergic reaction, itching, and rash. It can be treated easily with intravenous medication. These side effects can hamper the repeated adoption of plasmapheresis, which restricts the growth of this market to a certain extent.
Key Findings of the Plasmapheresis Market Study:
In 2023, the Disposables Segment is Expected to Dominate the Plasmapheresis Market
Based on product, the plasmapheresis market is segmented into instruments and disposables. In 2023, the disposables segment is expected to account for the larger share of the plasmapheresis market. The disposables include consumables such as plasma separation filters and administration sets. The large market share of this segment is attributed to the rising requirement for new disposables with each increasing plasmapheresis procedure or session.
In 2023, the Centrifugation Segment is Expected to Dominate the Plasmapheresis Market
Based on technology, the plasmapheresis market is segmented into centrifugation and membrane filtration. In 2023, the centrifugation segment is expected to account for the larger share of the plasmapheresis market. The large market share of this segment is attributed to the higher adoption of centrifugation technology in donor apheresis due to its various advantages, such as cost-effectiveness in related disposables and more efficient removal of plasma.
In 2023, the Source Plasma Collection Segment is Expected to Dominate the Plasmapheresis Market
Based on application, the plasmapheresis market is segmented into source plasma collection and therapeutic plasmapheresis. In 2023, the source plasma collection segment is expected to account for the larger share of the plasmapheresis market. The large market share of this segment is attributed to the huge demand for source plasma from biopharmaceutical companies for plasma fractionation and production of plasma proteins.
In 2023, the Blood Banks & Plasma Collection Centers Segment is Expected to Dominate the Plasmapheresis Market
Based on end user, the plasmapheresis market is segmented into blood banks & plasma collection centers, hospitals & clinics, biopharmaceutical companies and other end users. In 2023, the blood banks & plasma collection centers segment is expected to account for the largest share of the plasmapheresis market. The large market share of this segment is attributed to the increasing awareness about donating plasma for plasma-derived therapies and favorable reimbursement policies for plasmapheresis procedures.
Asia-Pacific: The Fastest-growing Regional Market
Asia-Pacific is slated to record the highest CAGR in the plasmapheresis market during the forecast period. The growth of this market is driven by the rapidly growing healthcare sector, rising demand for plasma-derived products, and the growing medical tourism industry in the region.
Key Players:
The report includes a competitive landscape based on an extensive assessment of the market based on product, technology, application, end user, and geography. The report also provides insights into the geographic presence of major market players and their key growth strategies in the last three to four years. The key players profiled in the plasmapheresis market are Asahi Kasei Corporation (Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), SB-Kawasumi Laboratories, Inc (Japan), Kaneka Corporation (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Shanghai Dahua Medical Apparatus Co., Ltd. (China), and Infomed SA (Switzerland).
Scope of the Report:
Plasmapheresis Market, by Product
Plasmapheresis Market, by Technology
Plasmapheresis Market, by Application
Plasmapheresis Market, by End User
Plasmapheresis Market, by Geography
Key questions answered in the report:
This market study covers the market sizes & forecasts of the plasmapheresis market based on product, technology, application, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the plasmapheresis market at the regional and country levels.
The plasmapheresis market is projected to reach $2.55 billion by 2030, at a CAGR of 8.6% during the forecast period of 2023–2030.
Based on product, the plasmapheresis market is segmented into instruments and disposables. In 2023, the disposables segment is expected to account for the larger share of the plasmapheresis market due to the recurring demand for disposables for plasmapheresis procedures, rising utilization of plasmapheresis for therapeutic purposes, and increasing awareness about plasma donations.
Based on technology, the plasmapheresis market is segmented into membrane filtration and centrifugation. In 2023, the centrifugation segment is expected to account for the larger share of the plasmapheresis market due to the high utilization of centrifugation technology for plasmapheresis and its various advantages, such as cost-effectiveness and efficient separation of plasma from blood cells.
Based on application, the plasmapheresis market is segmented into source plasma collection and therapeutic plasmapheresis. In 2023, the source plasma collection segment is expected to account for the larger share of the plasmapheresis market due to the high demand for the source plasma from biopharmaceutical companies and the growing number of plasma donations.
Based on end user, the plasmapheresis market is segmented into blood banks & plasma collection centers, hospitals & clinics, biopharmaceutical companies and other end users. In 2023, the blood banks & plasma collection centers segment is expected to account for the largest share of the plasmapheresis market due to increasing awareness about donating plasma for plasma-derived therapies and favorable reimbursement policies for plasmapheresis procedures.
The growth of this market is driven by the rising incidence of autoimmune diseases, increasing demand for source plasma from biopharmaceutical companies, and favorable reimbursement policies for plasmapheresis procedures. In addition, the rising demand for plasmapheresis from emerging countries is expected to provide significant market growth opportunities.
The high cost of plasmapheresis devices & procedures and the risks associated with plasmapheresis procedures are expected to hinder the growth of this market to a certain extent. In addition, factors such as the lack of awareness about plasmapheresis procedures and limited access and availability in certain regions are the major challenges to the growth of this market.
The key players operating in the plasmapheresis market are Asahi Kasei Corporation (Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), Kawasumi Laboratories Inc. (Japan), Kaneka Corporation (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Shanghai Dahua Medical Apparatus Co. Ltd. (China), and Infomed SA (Switzerland).
Asia-Pacific is slated to register the highest CAGR during the forecast period and offer significant growth opportunities for the players in this market. The high market growth in Asia-Pacific is driven by the rapidly growing healthcare sector, rising demand for plasma-derived products, and the growing medical tourism industry in the region.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Incidence of Autoimmune Diseases
4.2.2. Increasing Demand for Source Plasma from Biopharmaceutical Companies
4.2.3. Favorable Reimbursement Policies for Plasmapheresis Procedures
4.3. Restraints
4.3.1. High Cost of Plasmapheresis Devices & Procedures
4.3.2. Risk Associated with Plasmapheresis Procedures
4.4. Opportunities
4.4.1. Rising Demand for Plasmapheresis from Emerging Countries
4.5. Challenges
4.5.1. Lack of Awareness About Plasmapheresis Procedures
4.5.2. Limited Access and Availability in Certain Regions
4.6. The Impact of COVID-19 on the Global Plasmapheresis Market
4.7. Regulatory Analysis
5. Global Plasmapheresis Market, by Product
5.1. Introduction
5.2. Instruments
5.3. Disposables
6. Global Plasmapheresis Market, by Technology
6.1. Introduction
6.2. Centrifugation
6.3. Membrane Filtration
7. Global Plasmapheresis Market, by Application
7.1. Introduction
7.2. Source Plasma Collection
7.3. Therapeutic Plasmapheresis
7.3.1. Immunology
7.3.2. Neurology
7.3.3. Hematology
7.3.4. Critical Care
7.3.5. Hematology-oncology
7.3.6. Rheumatology & Orthopedics
7.3.7. Other Therapeutic Applications
8. Global Plasmapheresis Market, by End User
8.1. Introduction
8.2. Blood Banks & Plasma Collection Centers
8.3. Hospital & Clinics
8.4. Biopharmaceutical Companies
8.5. Other End Users
9. Plasmapheresis Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Switzerland
9.3.7. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. Australia
9.4.4. India
9.4.5. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.6. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Dashboard
10.4. Vendor Market Positioning
10.5. Market Share Analysis (2022)
11. Company Profiles (Business Overview, Financial Overview, Product Overview, and Strategic Developments)
11.1. Asahi Kasei Corporation
11.2. Terumo Corporation
11.3. Baxter International Inc.
11.4. B. Braun Melsungen AG
11.5. SB-Kawasumi Laboratories, Inc.
11.6. Kaneka Corporation
11.7. Haemonetics Corporation
11.8. Fresenius SE & Co. KGaA
11.9. Shanghai Dahua Medical Apparatus Co., Ltd.
11.10. Infomed SA
12. Appendix
12.1. Questionnaire
12.2. Available Customization
List of Tables
Table 1 Global Plasmapheresis Market: Impact Analysis of Market Drivers (2023–2030)
Table 2 Global Plasmapheresis Market: Impact Analysis of Market Restraints (2023–2030)
Table 3 Global Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 4 Global Plasmapheresis Instruments Market Size, by Country/Region, 2021–2030 (USD Million)
Table 5 Global Plasmapheresis Disposables Market Size, by Country/Region, 2021–2030 (USD Million)
Table 6 Global Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 7 Global Plasmapheresis Market Size for Centrifugation, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Plasmapheresis Market Size for Membrane Filtration, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 10 Global Plasmapheresis Market Size for Source Plasma Collection, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Plasmapheresis Market Size for Therapeutic Plasmapheresis, by Type, 2021–2030 (USD Million)
Table 12 Global Plasmapheresis Market Size for Therapeutic Plasmapheresis, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Therapeutic Plasmapheresis Market Size for Immunology, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Therapeutic Plasmapheresis Market Size for Neurology, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Therapeutic Plasmapheresis Market Size for Hematology, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Therapeutic Plasmapheresis Market Size for Critical Care, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Therapeutic Plasmapheresis Market Size for Hematology-oncology, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Therapeutic Plasmapheresis Market Size for Rheumatology & Orthopedics, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Therapeutic Plasmapheresis Market Size for Other Therapeutic Applications, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 21 Global Plasmapheresis Market Size for Blood Banks & Plasma Collection Centers, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Plasmapheresis Market Size for Hospital & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Plasmapheresis Market Size for Biopharmaceutical Companies, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Plasmapheresis Market Size for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 25 Global Plasmapheresis Market Size, by Country/Region, 2021–2030 (USD Million)
Table 26 North America: Plasmapheresis Market Size, by Country, 2021–2030 (USD Million)
Table 27 North America: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 28 North America: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 29 North America: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 30 North America: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 31 North America: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 32 U.S.: Key Micro Indicators
Table 33 U.S.: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 34 U.S.: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 35 U.S.: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 36 U.S.: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 37 U.S.: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 38 Canada: Key Micro Indicators
Table 39 Canada: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 40 Canada: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 41 Canada: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 42 Canada: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 43 Canada: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 44 Europe: Plasmapheresis Market Size, by Country/Region, 2021–2030 (USD Million)
Table 45 Europe: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 46 Europe: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 47 Europe: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 48 Europe: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 49 Europe: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 50 Germany: Key Micro Indicators
Table 51 Germany: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 52 Germany: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 53 Germany: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 54 Germany: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 55 Germany: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 56 France: Key Micro Indicators
Table 57 France: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 58 France: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 59 France: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 60 France: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 61 France: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 62 U.K.: Key Micro Indicators
Table 63 U.K.: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 64 U.K.: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 65 U.K.: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 66 U.K.: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 67 U.K.: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 68 Italy: Key Micro Indicators
Table 69 Italy: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 70 Italy: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 71 Italy: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 72 Italy: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 73 Italy: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 74 Spain: Key Micro Indicators
Table 75 Spain: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 76 Spain: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 77 Spain: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 78 Spain: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 79 Spain: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 80 Switzerland: Key Micro Indicators
Table 81 Switzerland: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 82 Switzerland: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 83 Switzerland: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 84 Switzerland: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 85 Switzerland: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 86 RoE: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 87 RoE: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 88 RoE: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 89 RoE: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 90 RoE: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 91 Asia-Pacific: Plasmapheresis Market Size, by Country/Region, 2021–2030 (USD Million)
Table 92 Asia-Pacific: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 93 Asia-Pacific: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 94 Asia-Pacific: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 95 Asia-Pacific: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 96 Asia-Pacific: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 97 Japan: Key Micro Indicators
Table 98 Japan: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 99 Japan: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 100 Japan: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 101 Japan: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 102 Japan: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 103 China: Key Micro Indicators
Table 104 China: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 105 China: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 106 China: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 107 China: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 108 China: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 109 Australia: Key Micro Indicators
Table 110 Australia: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 111 Australia: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 112 Australia: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 113 Australia: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 114 Australia: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 115 India: Key Micro Indicators
Table 116 India: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 117 India: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 118 India: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 119 India: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 120 India: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 121 RoAPAC: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 122 RoAPAC: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 123 RoAPAC: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 124 RoAPAC: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 125 RoAPAC: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 126 Latin America: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 127 Latin America: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 128 Latin America: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 129 Latin America: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 130 Latin America: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 131 Middle East & Africa: Plasmapheresis Market Size, by Product, 2021–2030 (USD Million)
Table 132 Middle East & Africa: Plasmapheresis Market Size, by Technology, 2021–2030 (USD Million)
Table 133 Middle East & Africa: Plasmapheresis Market Size, by Application, 2021–2030 (USD Million)
Table 134 Middle East & Africa: Therapeutic Plasmapheresis Market Size, by Type, 2021–2030 (USD Million)
Table 135 Middle East & Africa: Plasmapheresis Market Size, by End User, 2021–2030 (USD Million)
Table 136 Recent Developments, by Company (2020–2023)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Plasmapheresis Market Size, by Product, 2023 Vs. 2030 (USD Million)
Figure 8 Global Plasmapheresis Market Size, by Technology, 2023 Vs. 2030 (USD Million)
Figure 9 Global Plasmapheresis Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 10 Global Plasmapheresis Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Plasmapheresis Market Size, by Geography
Figure 12 Market Dynamics
Figure 13 Global Plasmapheresis Market Size, by Product, 2023 Vs. 2030 (USD Million)
Figure 14 Global Plasmapheresis Market Size, by Technology, 2023 Vs. 2030 (USD Million)
Figure 15 Global Plasmapheresis Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 16 Global Plasmapheresis Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 17 Global Plasmapheresis Market Size, by Region, 2023 Vs. 2030 (USD Million)
Figure 18 North America: Plasmapheresis Market Snapshot
Figure 19 Europe: Plasmapheresis Market Snapshot
Figure 20 Asia-Pacific: Plasmapheresis Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players (2020–2023)
Figure 22 Plasmapheresis Market: Competitive Dashboard
Figure 23 Plasmapheresis Market: Competitive Benchmarking by Product
Figure 24 Plasmapheresis Market: Competitive Benchmarking by Geography
Figure 25 Market Share Analysis: Plasmapheresis Market (2022)
Figure 26 Asahi Kasei Corporation: Financial Overview (2022)
Figure 27 Terumo Corporation: Financial Overview (2022)
Figure 28 Baxter International Inc.: Financial Overview (2022)
Figure 29 Kaneka Corporation: Financial Overview (2022)
Figure 30 Haemonetics Corporation: Financial Overview (2022)
Figure 31 Fresenius SE & Co. KGaA: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
